Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2023-06-19 13:38 Tx date 2023-06-15 |
$GUD
Knight Therapeutics Inc. |
Montejo, Ricardo Adolfo
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,292
+466 vol $4.92 each |
873 | |
Filed 2023-04-03 21:58 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Montejo, Ricardo Adolfo
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$20,019
+4,509 vol $4.44 each |
12,970 | |
Filed 2023-04-03 21:57 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Montejo, Ricardo Adolfo
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$20,019
+4,509 vol $4.44 each |
12,970 | |
Filed 2023-03-19 23:19 Tx date 2023-03-15 |
$GUD
Knight Therapeutics Inc. |
Montejo, Ricardo Adolfo
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,051
+407 vol $5.04 each |
407 | |
Filed 2023-03-19 23:16 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Montejo, Ricardo Adolfo
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-03-29 11:43 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Montejo, Ricardo Adolfo
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$24,174
+4,640 vol $5.21 each |
8,461 | |
Filed 2022-03-29 11:43 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Montejo, Ricardo Adolfo
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$24,174
+4,640 vol $5.21 each |
8,461 | |
Filed 2021-09-03 09:21 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Montejo, Ricardo Adolfo
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
3,821 | ||
Filed 2021-09-03 09:20 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Montejo, Ricardo Adolfo
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
3,821 | ||
Filed 2021-09-02 16:27 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Montejo, Ricardo Adolfo
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-09-02 16:19 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Montejo, Ricardo Adolfo
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-09-02 16:27 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Montejo, Ricardo Adolfo
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
3,822 | ||
Filed 2021-09-02 16:19 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Montejo, Ricardo Adolfo
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
3,822 |